Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

10816	Companies
234404	Keywords
163259	Articles
125410	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 10/29/2024 at 11:46, 1 year 9 months ago

Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome

Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF

published on 10/28/2024 at 12:31, 1 year 9 months ago

Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board

Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
BRIEF

published on 10/28/2024 at 12:31, 1 year 9 months ago

Ken Herrmann, expert en médecine nucléaire, rejoint le conseil d'administration de Pentixapharm

Conseil De Surveillance Produits Radiopharmaceutiques Médecine Nucléaire Ken Herrmann Pipeline En Oncologie
PRESS RELEASE

published on 10/28/2024 at 12:26, 1 year 9 months ago

Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline

Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF

published on 10/25/2024 at 16:05, 1 year 9 months ago

Pentixapharm Holding AG Announces Leadership Changes

Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
BRIEF

published on 10/25/2024 at 16:05, 1 year 9 months ago

Pentixapharm Holding AG annonce des changements au sein de sa direction

Conseil De Surveillance Changements De Direction Pentixapharm Docteur Hakim Bouterfa Dr Dirk Pleimes
PRESS RELEASE

published on 10/25/2024 at 16:00, 1 year 9 months ago

Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group
Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments

CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF

published on 10/19/2024 at 12:33, 1 year 9 months ago

Pentixapharm's CXCR4 Compound Showcased at EANM Conference

Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
BRIEF

published on 10/19/2024 at 12:33, 1 year 9 months ago

Le composé CXCR4 de Pentixapharm présenté à la conférence EANM

Produits Radiopharmaceutiques Pentixapharm Ciblage CXCR4 Conférence EANM Développement Théranostique
PRESS RELEASE

published on 10/19/2024 at 12:28, 1 year 9 months ago

Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM)
Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas

Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress

Accesswire

Published on 08/10/2026 at 15:30, 5 hours 2 minutes ago

Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 5 hours 7 minutes ago

Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 6 hours 2 minutes ago

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 7 hours 2 minutes ago

Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 7 hours 32 minutes ago

Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 20:24, 7 minutes ago

EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 56 minutes ago

Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 1 hour 31 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Published on 08/10/2026 at 18:29, 2 hours 2 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 17:50, 2 hours 41 minutes ago

Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report

Les Echos

Published on 08/10/2026 at 18:00, 2 hours 32 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 hours 32 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 hours 47 minutes ago

Weekly share buyback
Published on 08/10/2026 at 17:45, 2 hours 47 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 8 hours 38 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE